Skip to content

A proven service model designed for supplying orphan drugs in Europe and beyond.

Over the past 30 years we’ve built a strong, flexible, and reliable international cold chain delivery network that provides validated lanes for both European and international distribution.

Our comprehensive range of services includes:

An established infrastructure

We operate a GDP-certified medical warehouse hub in the Netherlands, equipped for all temperature regimes, facilitating delivery to most European sites within 24 to 48 hours.

GMP late-stage customization

We offer a late-stage customization service which enables us to ship precise amounts of stock directly to the receiving country with the local information and serial numbers.

compassionate use

Compliance with local country regulations

We have regulatory licensing including wholesale distribution authorisation (WDA), that allows us for the movement of pre-licensed and licensed drug products via GDP solutions.

A multilingual customer service

Our international customer liaison team, based in Germany, is multilingual and proficient in most European languages. They provide a variety of support services and serve as the primary point of contact for hospitals and pharmacies.

A comprehensive order to cash service

Once our dedicated team has taken an order, we can proactively manage stock movements and take control of the complete supply process across warehousing, customer communications, delivery and cash collection.

Early Access Programs Challenges

International delivery network

Our delivery network provides validated lanes for European & Global distribution. Most European sites can be reached within 24–48 hours from our site in the Netherlands, with a pre-9 or pre-12  urgent service available.

Discover more about our distribution offer from our Logistics Director.

Purple_Holding-paper

Request a quote

Get in touch with our team today!

Our numbers

Sciensus can make the typically complex process of rare disease medicine supply and distribution across Europe’s 28 countries very simple.

0

Deliveries

0

Countries

> 0.00 %

On-time delivery

Why choose Sciensus?

Green_Hand heart

Industry leading experience

Sciensus has a 30-year proven track record in collaborating with US biotech companies to find patients and expand access to rare and orphan medications in Europe and beyond.

Green_Account

A single partner for all your needs

We can carry out all activities in the rare and ultra-rare disease space, from early access programs and patient support programs to full commercialization and a bespoke supply chain.

ESG icon - communites

Bespoke solutions for orphan drug supply

Our team’s extensive expertise has been used to design our fully flexible approach, and our facilities have been created especially for low volume, rare medication.

Request a quote

Get in touch with our team today!